SCHEMBL4889625

SCHEMBL4889625

Cc1cc(NC(=O)c2cccc(C(F)(F)F)c2F)nn1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBLB Q13191 1/20 0.46
KAT6A Q92794 2/20 0.46
SORT1 Q99523 2/20 0.45
CTSS P25774 1/20 0.45
TEK Q02763 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
TAS1R2 Q8TE23 1/20 0.44
RECQL P46063 1/20 0.42
KCNK3 O14649 2/20 0.41
KCNK9 Q9NPC2 2/20 0.41
NR3C1 P04150 1/20 0.41
GRM5 P41594 1/20 0.41
PTGS1 P23219 1/20 0.40
AURKA O14965 1/20 0.40
AURKB Q96GD4 1/20 0.40
RORA P35398 1/20 0.40
NR2E1 Q9Y466 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847509 0.85 ALDH1A1 (0.48) KAT6AALDH1A1LMNAGRM5
SCHEMBL26847445 0.80 SMN1; SMN2 (0.56) ALDH1A1LMNA
SCHEMBL17894008 0.77 CRACR2A (0.45) SORT1ALDH1A1GRM5
SCHEMBL25143261 0.77 NPC1 (0.57) ALDH1A1LMNAKCNK3KCNK9
SCHEMBL25143098 0.75 ALDH1A1 (0.48) ALDH1A1LMNAGRM5
SCHEMBL25142737 0.73 LMNA (0.48) ALDH1A1LMNA
SCHEMBL31665411 0.73 LMNA (0.48) ALDH1A1LMNA
SCHEMBL9134374 0.72 ALDH1A1 (0.54) ALDH1A1LMNAGRM5
SCHEMBL26847552 0.72 ALDH1A1 (0.56) ALDH1A1LMNANR2E1
SCHEMBL25407860 0.72 KMT2A (0.42) KAT6AALDH1A1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312435-A1 Imine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-18 US disclosed
US-20080312435-A1 Imine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-18 US disclosed
US-20080312435-A1 Imine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-18 US disclosed
CN-101065125-A Imine compound TAISHO PHARMACEUTICAL CO LTD (JP) 2007-10-31 CN disclosed
EP-1820504-A1 IMINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312435-A1 Imine Compound CNR1, CNR2, HRH4 CBLB 4199/4885KAT6A 2253/4885SORT1 4852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.